{"transactions":[{"id":2918648,"issuer":{"id":7947,"kind":"organization","name":"MetaVia Inc.","symbol":"MTVA"},"owners":[{"id":144116,"kind":"person","name":"Bakshi Akash","position":1,"cik":"0001836243","reported_name":"Bakshi Akash","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and COO"}}],"security":"Common Stock","published_at":"2021-01-05T21:09:02.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":855059,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for shares of ANA Therapeutics, Inc. (\"ANA\") common stock in connection with the acquisition of ANA by the Company."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reportable securities are owned directly by YourChoice Holdings, LLC (\"YourChoice\"). Mr. Bakshi is the CEO and a director of YourChoice. Mr. Bakshi disclaims beneficial ownership of the securities reported herein for the purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of his pecuniary interest therein, if any."}],"balance_after":884072,"source":{"system":"sec-edgar","filing":"0001104659-21-000919","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1638287/000110465921000919/a4.xml","form_type":"4"}},{"id":2918647,"issuer":{"id":7947,"kind":"organization","name":"MetaVia Inc.","symbol":"MTVA"},"owners":[{"id":144116,"kind":"person","name":"Bakshi Akash","position":1,"cik":"0001836243","reported_name":"Bakshi Akash","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and COO"}}],"security":"Common Stock","published_at":"2021-01-05T21:09:02.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":29013,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for shares of ANA Therapeutics, Inc. (\"ANA\") common stock in connection with the acquisition of ANA by the Company."}],"balance_after":29013,"source":{"system":"sec-edgar","filing":"0001104659-21-000919","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638287/000110465921000919/a4.xml","form_type":"4"}}]}